Dr. Bardia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2336 Santa Monica Blvd
Ste 304
Santa Monica, CA 90404Phone+1 310-998-4747
Education & Training
- All India Institute of Medical SciencesClass of 2003
Certifications & Licensure
- CA State Medical License 2024 - 2026
- MA State Medical License 2011 - 2025
- MD State Medical License 2008 - 2012
- MN State Medical License 2007 - 2008
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer Start of enrollment: 2017 Dec 12
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Dynamic HER2-low status among patients with triple negative breast cancer (TNBC) and the impact of repeat biopsies.Yael Bar, Geoffrey Fell, Aylin Dedeoglu, Natalie Moffett, Neelima Vidula
NPJ Breast Cancer. 2025-03-11 - A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative).Hope S Rugo, Peter Schmid, Sara M Tolaney, Frederik Marmé, Aditya Bardia
Future Oncology. 2025-03-01 - Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates.Laura Pala, Federico Merlo, Isabella Sala, Eleonora Pagan, Chiara Oriecuia
Journal of the National Cancer Institute. 2025-02-25
Press Mentions
- Racial Disparities in Genomic Profiles, Treatment Found in Patients with Metastatic Breast CancerFebruary 28th, 2025
- SABCS 2024 Showcases Promising Breast Cancer Treatments and ApproachesFebruary 12th, 2025
- ENHERTU Receives Approval for HER2-Directed Therapy for Patients with HER2-Low or HER2-Ultralow Metastatic Breast CancerFebruary 3rd, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: